Histamine as a Molecular Transducer of Adaptation to Exercise

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 28, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Postexercise Hypotension
Interventions
BEHAVIORAL

Aerobic Exercise

Subjects will complete a single bout of aerobic exercise.

DRUG

alpha-FMH

Subjects will undergo either local heating with diathermy or whole body heating with far-infrared sauna.

BEHAVIORAL

Resistance and Aerobic Exercise

Subjects will complete bouts of resistance and aerobic exercise.

DRUG

Antihistamine

Subjects will complete a single bout of aerobic exercise under placebo vs antihistamine conditions.

Trial Locations (1)

97403

RECRUITING

University of Oregon, Eugene

All Listed Sponsors
lead

University of Oregon

OTHER